Gilead Sciences has been granted a patent for compounds to treat HIV infection, with a specific Formula (I) outlined. The patent also covers methods for preparation and use of the compounds, along with pharmaceutical compositions. GlobalData’s report on Gilead Sciences gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Gilead Sciences, Peptide pharmacophores was a key innovation area identified from patents. Gilead Sciences's grant share as of January 2024 was 44%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent (Publication Number: US11883397B2) discloses a compound with a specific chemical formula (Formula I) and its variations (Formulas IV and IV-A). The compound, along with its pharmaceutically acceptable salts or stereoisomers, is characterized by different configurations of hydrogen and alkyl groups. Additionally, the patent covers compounds where the chemical structure includes phenyl groups substituted with halogen substituents, such as fluorine and chlorine, in various positions.
Furthermore, the patent includes claims related to pharmaceutical compositions containing the disclosed compound, along with carriers or excipients. These compositions are intended for modulating human immunodeficiency virus proliferation in individuals at risk of infection or already infected. The patent also outlines methods for administering the compound or the pharmaceutical composition to achieve the desired modulation of human immunodeficiency virus proliferation, emphasizing the therapeutic effectiveness of the disclosed compound in combating the virus.
To know more about GlobalData’s detailed insights on Gilead Sciences, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
